Cumulative incidence and risk factors of mitoxantrone-induced cardiotoxicity in children: a systematic review.
about
The effects of exercise on cardiovascular outcomes before, during, and after treatment for breast cancerMitoxantrone-Surfactant Interactions: A Physicochemical OverviewIs it possible to cure childhood acute myeloid leukaemia without significant cardiotoxicity?Mitoxantrone as a substitute for daunorubicin during induction in newly diagnosed lymphoblastic leukemia and lymphoma.Serial Assessment of Cardiac Function during and following Mitoxantrone Infusion in 30 Consecutive Patients with Multiple SclerosisMultifunctional yolk-in-shell nanoparticles for pH-triggered drug release and imaging.Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.Late Cardiac Events after Childhood Cancer: Methodological Aspects of the Pan-European Study PanCareSurFupAnthracycline cardiotoxicity.Pixantrone for the treatment of aggressive non-Hodgkin lymphoma.Can anthracycline therapy for pediatric malignancies be less cardiotoxic?Pharmacokinetic evaluation of pixantrone for the treatment of non-Hodgkin's lymphoma.Pixantrone: merging safety with efficacy.Relapsed and refractory pediatric acute myeloid leukemia: current and emerging treatments.Prevalence of cardiovascular late sequelae in long-term survivors of childhood cancer: A systematic review and meta-analysis.Surface functionalization of mesoporous silica nanoparticles controls loading and release behavior of mitoxantrone.Chemotherapy-induced cardiotoxicity in children.Mitoxantrone-Induced Cardiotoxicity in Acute Myeloid Leukemia-A Velocity Vector Imaging Analysis.Pre-clinical evaluation of 1-nitroacridine derived chemotherapeutic agent that has preferential cytotoxic activity towards prostate cancer.Prospective longitudinal evaluation of doxorubicin-induced cardiomyopathy in sarcoma patients: a report of the late effects surveillance system (LESS).Pixantrone (BBR 2778) has reduced cardiotoxic potential in mice pretreated with doxorubicin: comparative studies against doxorubicin and mitoxantrone.Exploring the Effects of Glycosylation and Etherification of the Side Chains of the Anticancer Drug Mitoxantrone.
P2860
Q26999300-8280E650-7C9A-4539-9B92-B36F209D5A1FQ28066259-B7B8168A-4F0A-4DB9-9099-2B27FABF373DQ30244600-B0E69019-8598-4842-AD00-481E017CC0EBQ35049636-DFFCB126-112B-4613-B206-591DBA07CBDFQ35380481-D42E8E1D-C248-4394-968E-2B5BC06BEA46Q35760777-555B795D-6A7C-477B-B70C-6618B4464401Q35797623-1A4EC31B-769E-4BA1-AC7F-29DF501A3529Q36137174-0665E60E-058C-45DA-8C57-8D61231DA49DQ36624983-9FFD213F-0986-4C27-9162-48AF97941BBDQ37766891-9BD94ED4-078A-4ADB-BA95-C322FC41EA3DQ37785821-660ED520-080F-44C1-9893-A50CCBA2FB7FQ37929798-42727224-495E-4D06-9839-F89C3B0E660BQ38078425-B054A43F-C6FA-4F4F-B435-1C7F03549616Q38155455-1F3E9B2B-5076-4846-9ABE-A6A46D27581DQ39138288-37D908DC-9AA3-42E5-A2C2-DBD55E5FD157Q39354128-4D9F416F-D0C9-4D7E-AF6C-7BA5185390D7Q39415815-8DD88D39-CE87-44BA-AF78-C5416707C309Q39826550-EC3E4094-E73A-4A7C-BE50-8DA8FBE23196Q40070852-3A80C628-ABAE-4E43-8E3D-6D75C7506084Q46840009-52C80ED3-E553-48F3-9E9B-7C3337F7EE2EQ51767579-43E879F5-E39C-40F4-AC03-E1FDE5267203Q53397800-67FF3D12-E715-42DC-AD96-ADE1705BF2EC
P2860
Cumulative incidence and risk factors of mitoxantrone-induced cardiotoxicity in children: a systematic review.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Cumulative incidence and risk ...... children: a systematic review.
@ast
Cumulative incidence and risk ...... children: a systematic review.
@en
type
label
Cumulative incidence and risk ...... children: a systematic review.
@ast
Cumulative incidence and risk ...... children: a systematic review.
@en
prefLabel
Cumulative incidence and risk ...... children: a systematic review.
@ast
Cumulative incidence and risk ...... children: a systematic review.
@en
P2093
P1476
Cumulative incidence and risk ...... children: a systematic review.
@en
P2093
van Dalen EC
van der Pal HJ
P304
P356
10.1016/J.EJCA.2003.12.006
P577
2004-03-01T00:00:00Z